Go Deep
Lunai Bioworks Inc.
Lunai Bioworks Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -15,485 | -0.8 | -0.39 | -0.48 | 78.19 |
| Oct 2026 | -15,396 | -0.6 | -0.32 | -0.48 | 64.44 |
| Oct 2026 | -17,467 | -0.4 | -0.22 | -0.48 | 44.75 |
| Oct 2026 | -17,494 | -0.5 | -0.24 | -0.48 | 48.83 |
| Oct 2026 | -17,496 | -0.5 | -0.25 | -0.48 | 48.99 |
| Oct 2026 | -17,466 | -0.4 | -0.22 | -0.48 | 44.36 |
Lunai Bioworks Inc. Quarterly Results
| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 20,942.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -2,571,394.0 | -1,799,404.0 | 2,819,021.0 | -126,732,236.0 |
| EPS | -0.8 | -0.6 | 1.0 | — |
Lunai Bioworks Inc. Revenue & Profit: Last 4 Years
| Line Item | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -178,007,489.0 | -88,425,828.0 | -39,684,056.0 | -113,433,392.0 |
| EPS | -86.4 | -72.8 | -56.8 | -172.8 |
Lunai Bioworks Inc. Balance Sheet
| Line Item | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|
| Total Assets | 8,230,840.0 | 163,129,450.0 | 58,300,796.0 | 84,632,663.0 |
| Total Liabilities | 29,580,681.0 | 31,152,306.0 | 11,798,685.0 | 12,013,815.0 |
| Total Equity | -21,349,841.0 | 131,977,144.0 | 46,502,111.0 | 72,618,848.0 |
Owes vs Owns
Lunai Bioworks Inc. owed $1.97 for every $1 it owned in Mar 2026, up from $0.14 in Jun 2022.
| Period | Mar 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 1.97× | 3.59× | 0.19× | 0.20× | 0.14× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Lunai Bioworks Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Jun 2025
Cash & short-term investments 5.8%Fixed assets (tangible) 12.8%Intangible assets 74.5%Other assets 6.9%
How it's funded — Jun 2025
Short-term debt 31.9%Long-term debt 1.4%Payables 42.4%Other liabilities 24.2%
| Line Item | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 0.5 | 0.2 | 1.9 | 9.2 |
| Receivables | 0.0 | 1.1 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 1.1 | 1.8 | 1.4 | 1.7 |
| Intangible assets | 6.1 | 159.4 | 54.3 | 73.3 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.6 | 0.7 | 0.7 | 0.5 |
| Liabilities & equity | ||||
| Short-term debt | 9.4 | 2.5 | 4.6 | 1.2 |
| Long-term debt | 0.4 | 0.8 | 0.8 | 4.6 |
| Payables | 12.6 | 9.4 | 5.3 | 1.4 |
| Other liabilities | 7.2 | 18.4 | 1.1 | 4.8 |
| Shareholders' equity | -21.3 | 132.0 | 46.5 | 72.6 |
| Net tangible assets | -27.5 | -27.4 | -7.8 | -0.6 |
Lunai Bioworks Inc. Cash Flow
| Line Item | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|
| Operating Activities | -7,874,647.0 | -10,971,430.0 | -11,774,549.0 | -15,732,336.0 |
| Investing Activities | -500,000.0 | -1,260,179.0 | -29,774.0 | -5,156.0 |
| Financing Activities | 8,382,772.0 | 10,517,455.0 | 4,515,056.0 | 4,250,464.0 |